Printer Friendly

ANGEION CORPORATION RAISES ADDITIONAL $2.1 MILLION

 ANGEION CORPORATION RAISES ADDITIONAL $2.1 MILLION
 MINNEAPOLIS/ST. PAUL, Dec. 11 /PRNewswire/ -- Angeion Corporation


(NASDAQ: ANGN) announced today it has raised an additional $2.1 million in a private financing of which it will net $1.9 million. In September, the company raised approximately $1.9 million net in a private financing. The proceeds from these financings are used to fund the company's ongoing product development efforts to treat and cure irregular heartbeats.
 Minneapolis-based Angeion Corporation is a manufacturer of cardiovascular products. Angeion's subsidiaries, AngeLase, Inc., and AngeMed, Inc., are developing several products for treating arrhythmias. Angeion is also traded on the Boston Stock Exchange under the symbol ANI.
 -0- 12/11/91
 /CONTACT: Brenda Roth of Angeion, 612-550-9388/
 (ANGN ANI) CO: Angeion Corporation ST: Minnesota IN: MTC SU:


AL -- MN009 -- 1577 12/11/91 15:41 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 11, 1991
Words:139
Previous Article:SCHWARTZ CHEMICAL TO REDUCE USE OF TOXIC CHEMICALS AND PAY PENALTY FOR FAILURE TO REPORT PROPERLY
Next Article:NORTHWEST POWER PLANNING COUNCIL APPROVES SALMON RECOVERY MEASURES
Topics:


Related Articles
ANGEION RECEIVES ADDITIONAL MARKET APPROVAL FROM JAPANESE GOVERNMENT
ANGEION REPORTS FIRST QUARTER SALES UP 13 PERCENT
ANGEION REPORTS SECOND QUARTER FIGURES
ANGEION SELLS ACCESSORY DIVISION; FOCUSES EXCLUSIVELY ON TREATING ARRHYTHMIAS
ANGEION RECEIVES SEVEN PATENTS
ANGEION UPDATES SHAREHOLDERS AT ANNUAL MEETING
Angeion and ELA Medical Collaboration Becomes Effective
Angeion Announces Three News Items: $5 Million Equity Investment; U.S. Clinical Studies of AngeFix Lead System; and European CE Mark to Market...
Angeion Transfers Certain Technology to ELA Medical In Exchange for Return of Common Stock and Warrants.
Angeion Shareholders Approve Two Transactions; Noteholders Fail to Vote.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters